Drajesk J - Search Results

1

Clinical observation of liver chemistry abnormalities in asthmatics.

Katz DA, Isaacson JD, Han L, Drajesk JF, Comer GM, Heath-Chiozzi ME. Katz DA, et al. Among authors: drajesk jf. Curr Drug Saf. 2009 Sep;4(3):173-80. doi: 10.2174/157488609789006930. Epub 2009 Sep 1. Curr Drug Saf. 2009. PMID: 19534645

2

Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment.

Drazen JM, Yandava CN, Dubé L, Szczerback N, Hippensteel R, Pillari A, Israel E, Schork N, Silverman ES, Katz DA, Drajesk J. Drazen JM, et al. Among authors: drajesk j. Nat Genet. 1999 Jun;22(2):168-70. doi: 10.1038/9680. Nat Genet. 1999. PMID: 10369259 Clinical Trial.

3

Pharmacokinetics of a novel 5-lipoxygenase inhibitor (ABT-761) in pediatric patients with asthma.

Wong SL, Kearns GL, Kemp JP, Drajesk J, Chang M, Locke CS, Dube LM, Awni WM. Wong SL, et al. Among authors: drajesk j. Eur J Clin Pharmacol. 1998 Nov-Dec;54(9-10):715-9. doi: 10.1007/s002280050540. Eur J Clin Pharmacol. 1998. PMID: 9923573 Clinical Trial.

4

Dose-proportional pharmacokinetics of a new 5-lipoxygenase inhibitor, ABT-761, in healthy volunteers.

Wong SL, Drajesk J, Chang MS, Witt G, Awni WM. Wong SL, et al. Among authors: drajesk j. Biopharm Drug Dispos. 1998 Apr;19(3):159-62. doi: 10.1002/(sici)1099-081x(199804)19:3<159::aid-bdd80>3.0.co;2-o. Biopharm Drug Dispos. 1998. PMID: 9569998 Clinical Trial.

5

Pharmacokinetics and pharmacodynamics of single and multiple oral doses of a novel 5-lipoxygenase inhibitor (ABT-761) in healthy volunteers.

Wong SL, Drajesk J, Chang M, Lanni C, Witt G, Hansen R, Awni WM. Wong SL, et al. Among authors: drajesk j. Clin Pharmacol Ther. 1998 Mar;63(3):324-31. doi: 10.1016/S0009-9236(98)90164-3. Clin Pharmacol Ther. 1998. PMID: 9542476 Clinical Trial.

6

Pharmacokinetics of zileuton and its metabolites in patients with renal impairment.

Awni WM, Wong S, Chu SY, Patterson K, Hansen R, Machinist JM, Drajesk J, Keane WF, Halstenson CE. Awni WM, et al. Among authors: drajesk j. J Clin Pharmacol. 1997 May;37(5):395-404. doi: 10.1002/j.1552-4604.1997.tb04317.x. J Clin Pharmacol. 1997. PMID: 9156372 Clinical Trial.

7

The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects.

Van Schoor J, Joos GF, Kips JC, Drajesk JF, Carpentier PJ, Pauwels RA. Van Schoor J, et al. Among authors: drajesk jf. Am J Respir Crit Care Med. 1997 Mar;155(3):875-80. doi: 10.1164/ajrccm.155.3.9117020. Am J Respir Crit Care Med. 1997. PMID: 9117020 Clinical Trial.

8

Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma.

LeMaistre CF, Rosen S, Frankel A, Kornfeld S, Saria E, Meneghetti C, Drajesk J, Fishwild D, Scannon P, Byers V. LeMaistre CF, et al. Among authors: drajesk j. Blood. 1991 Sep 1;78(5):1173-82. Blood. 1991. PMID: 1878584 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters